23 May 2013
Keywords: crestor, ezetimibe, reduce, crp, levels, cd, study
Article | 11 September 2006
Data from a study of AstraZeneca's Crestor (rosuvastatin), show that the drug, in combination with ezetimibe, brought about a 46% reduction ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 September 2006
22 May 2013
© 2013 thepharmaletter.com